PET finds early coronary disease in diabetic patients

Article

PET may be diagnostically more powerful than ultrasound or CT for identifying early coronary artery disease in patients with type 2 diabetes.

PET may be diagnostically more powerful than ultrasound or CT for identifying early coronary artery disease in patients with type 2 diabetes.

Nuclear cardiologist Dr. Thomas Schindler and colleagues at the University of Geneva in Switzerland and the University of California, Los Angeles measured coronary endothelium dysfunction with nitrogen-13 ammonia PET and rest-stress PET.

They found diabetes patients with normal or elevated blood pressure showed significantly stronger signs of vascular disease than did normal controls. They also compared PET with high-resolution vascular ultrasound and multislice CT coronary calcium tests and found PET more sensitive than either sonography or CT. Results were presented at the 2008 SNM meeting.

Recent Videos
Improving Access to Nuclear Imaging: An Interview with SNMMI President Jean-Luc C. Urbain, MD, PhD
SNMMI: 18F-Piflufolastat PSMA PET/CT Offers High PPV for Local PCa Recurrence Regardless of PSA Level
SNMMI: NIH Researcher Discusses Potential of 18F-Fluciclovine for Multiple Myeloma Detection
SNMMI: What Tau PET Findings May Reveal About Modifiable Factors for Alzheimer’s Disease
Emerging Insights on the Use of FES PET for Women with Lobular Breast Cancer
Can Generative AI Reinvent Radiology Reporting?: An Interview with Samir Abboud, MD
Mammography Study Reveals Over Sixfold Higher Risk of Advanced Cancer Presentation with Symptom-Detected Cancers
Combining Advances in Computed Tomography Angiography with AI to Enhance Preventive Care
Study: MRI-Based AI Enhances Detection of Seminal Vesicle Invasion in Prostate Cancer
What New Research Reveals About the Impact of AI and DBT Screening: An Interview with Manisha Bahl, MD
Related Content
© 2025 MJH Life Sciences

All rights reserved.